717 related articles for article (PubMed ID: 8675088)
41. Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease.
Bene L; Füst G; Huszti Z; Hernádi Z; Fekete B; Mészáros M; Veres A; Kovács A; Miklós K; Singh M; Romics L; Prohászka Z
Dig Dis Sci; 2002 Jul; 47(7):1432-7. PubMed ID: 12141797
[TBL] [Abstract][Full Text] [Related]
42. Serum antibodies to cow's milk proteins in pediatric inflammatory bowel disease: Crohn's disease vs. ulcerative colitis.
Lerner A; Rossi TM; Park B; Albini B; Lebenthal E
Acta Paediatr Scand; 1989 Jan; 78(1):81-6. PubMed ID: 2919527
[TBL] [Abstract][Full Text] [Related]
43. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
[TBL] [Abstract][Full Text] [Related]
44. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease.
Reumaux D; Mézière C; Colombel JF; Duthilleul P; Mueller S
Clin Immunol Immunopathol; 1995 Dec; 77(3):349-57. PubMed ID: 7586746
[TBL] [Abstract][Full Text] [Related]
45. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
46. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
47. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
48. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.
Baumgart DC; Thomas S; Przesdzing I; Metzke D; Bielecki C; Lehmann SM; Lehnardt S; Dörffel Y; Sturm A; Scheffold A; Schmitz J; Radbruch A
Clin Exp Immunol; 2009 Sep; 157(3):423-36. PubMed ID: 19664152
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis.
Kapel N; Meillet D; Favennec L; Magne D; Raichvarg D; Gobert JG
Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):197-202. PubMed ID: 1525248
[TBL] [Abstract][Full Text] [Related]
50. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
51. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.
Mylonaki M; Rayment NB; Rampton DS; Hudspith BN; Brostoff J
Inflamm Bowel Dis; 2005 May; 11(5):481-7. PubMed ID: 15867588
[TBL] [Abstract][Full Text] [Related]
53. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
54. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
[TBL] [Abstract][Full Text] [Related]
55. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
57. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
58. Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.
Kuehbacher T; Rehman A; Lepage P; Hellmig S; Fölsch UR; Schreiber S; Ott SJ
J Med Microbiol; 2008 Dec; 57(Pt 12):1569-1576. PubMed ID: 19018031
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
[TBL] [Abstract][Full Text] [Related]
60. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
Sartor RB
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
